Samsung Electronics subsidiary NeuroLogica has obtained 510(k) approval from the US Food and Drug Administration (FDA) for its GC85A digital radiography (DR) system.
Samsung GC85A is a ceiling digital X-ray system, which is claimed to provide streamlined workflows, diagnostic confidence and improved total cost of ownership.
NeuroLogica global sales vice-president and chief marketing officer David Webster said: "The Samsung GC85A represents NeuroLogica’s latest commitment to introducing user- and patient-centric innovation to healthcare to provide fast, easy and accurate diagnoses.
"The system’s superior image quality and ease of control will enable users to experience a new level of efficiency with a DR system designed for streamlined operation."
The new DR system features S-Vue imaging engine, wireless and lightweight S-Detector, smart control, smart stitching, S-Align and S-Share compatibility.
Samsung’s other DR systems include mobile digital GM60A U-arm digital GU60A and ceiling digital GC80.
NeuroLogica also produces products such as CereTom for brain imaging, inSPira HD for bedside imaging and BodyTom, a full body 32-slice CT scanner with an 85cm gantry.
Image: NeuroLogica obtains FDA approval for GC85A DR system. Photo: courtesy of NeuroLogica Corporation.